Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy

Clinical Infectious Diseases

Volumn 27, Issue 5, 1998, Pages 1255-1258

  Zylberberg, Hervé ^a,b   Pialoux, Gilles ^a   Carnot, Françoise ^a   Landau, Alain ^a   Bréchot, Christian ^a   Pol, Stanislas ^a  

^a Hopital Laennec   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG MIXTURE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER CIRRHOSIS; PRIORITY JOURNAL;

EID: 0032466517     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514987     Document Type: Article

References (14)

1. Lipsky JJ. Antiretroviral drugs for AIDS. Lancet 1996; 348:800-3.
2. Gerber MA. Pathobiologic effects of hepatitis C. J Hepatol 1995; 22(suppl 1):83-6.
3. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347: 92-3.
4. Zylberberg H, Chaix M-L, Rabian C, et al. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects. Clin Infect Dis 1998; 26:1104-6.
5. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-5.
6. 5a. Koehler JE, Sanchez MA, Garrido CS, et al. Molecular epidemiology of Bartonella infections in patients with bacillary angiomatosis peliosis. N Engl J Med 1997; 337:1876-83.
7. Zylberberg H, Carnot F, Mamzer MF, Blancho G, Pol S. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997; 63:158-60.
8. Lim HL, Lau GKK, Davis GL, Dolson DJ, Lau JYN. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994; 106:248-51.
9. Nelson DR, Marousis CG, Davis GL, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158:1473-81.
10. Ballardini G, Groff P, Pontisso P, et al. Hepatitis C virus genotype, tissue HCV antigens, hepatocellular expression of HLA-A, B, C, and intercellular adhesion-1 molecules: clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995; 95:2067-75.
11. Carr A, Emery S, Kelleher A, Law M, Cooper DA. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:320-6.
12. Pol S, Lamorthe B, Thi NT, et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 1998; 28:945-50.
13. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989; 97:1559-61.
14. Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needlestick injury. N Engl J Med 1997; 336:919-22.